In this study, we tested the hypothesis that naringin has anticancer actions through inhibition of Zeb1, a zinc finger homeodomain transcription factor implicated in invasiveness and metastasis development in several tumor types, including osteosarcoma and lung cancer [25–27]. The gene discussed is ZEB1; the disease is neoplasm.